Wednesday, June 10, 2026
🇺🇸 FDA

pharma · Hepatitis B · Mixed Dyslipidemia · ARWR

Arrowhead Pharmaceuticals Ireland

Arrowhead Pharmaceuticals Ireland Limited

Arrowhead Pharmaceuticals Ireland trial registry — 70 ClinicalTrials.gov studies with program phase, status, and indication context.

Website Investor relations
177 E Colorado Blvd, Suite 700, Pasadena, California 91105, US HQ
746 Employees
Public company Type
ARWR · NYSE Ticker
Company details
Status
Public
HQ
177 E Colorado Blvd, Suite 700, Pasadena, California 91105, US
Employees
746
Programs
63
Drugs
34
Patents
126
Official website ↗ All projects Drug pipeline Patents News & analysis

Recent coverage

View all news & analysis →
Intelligence · Clinical Trials

Arrowhead Pharmaceuticals Ireland clinical trials

Registry index of 70 ClinicalTrials.gov studies linked to Arrowhead Pharmaceuticals Ireland programs — each row shows trial ID, program name, phase, status, and indication.

Arrowhead Pharmaceuticals Ireland trial registry — 70 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

8 updates

Latest clinical program signals indexed for Arrowhead Pharmaceuticals Ireland.

  1. AROMUC5AC-1001 — Phase 2

    Clinical update

  2. AROAPOC3-3001 — Phase 3

    Clinical update

  3. 0.9% Sodium chloride - inhalation solution — Phase 2

    Clinical update

  4. Study of ARO-ATXN2 Injection in Adults With Spinocerebellar Ataxia Type 2 — Phase 1

    Clinical update

  5. Plozasiran Injection Placebo, ARO-APOC3 PFS — Phase 3

    Clinical update

  6. ARO-APOC3 PFS, Plozasiran Injection Placebo — Phase 3

    Clinical update

  7. Plozasiran Injection Placebo, ARO-APOC3 PFS — Phase 3

    Clinical update

  8. ARO-APOC3 PFS, Plozasiran Injection Placebo — Phase 3

    Clinical update

Trial registry

70 studies

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.